Literature DB >> 22015388

Serum triglycerides and risk of cardiovascular disease.

A C I Boullart1, J de Graaf, A F Stalenhoef.   

Abstract

Dyslipidemia, especially elevated serum levels of cholesterol, is causally related to cardiovascular disease. The specific role of triglycerides has long been controversial. In this article we discuss the role of serum triglycerides in relation to the risk of cardiovascular disease. First, the (patho)physiology of triglycerides is described, including the definition and a short summary of the primary and secondary causes of hypertriglyceridemia. Furthermore, we will give an overview of the published epidemiological studies concerning hypertriglyceridemia and cardiovascular disease to support the view that triglyceride-rich lipoproteins are an independently associated risk factor. Finally, treatment strategies and treatment targets are discussed. This article is part of a Special Issue entitled Triglyceride Metabolism and Disease.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22015388     DOI: 10.1016/j.bbalip.2011.10.002

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  42 in total

Review 1.  Postprandial metabolism of meal triglyceride in humans.

Authors:  Jennifer E Lambert; Elizabeth J Parks
Journal:  Biochim Biophys Acta       Date:  2012-01-17

2.  A snapshot of lipid levels in the Republic of Ireland in 2017.

Authors:  Ruth Agar; Catherine Markham; Meabh Prendergast; Rebecca Canning; Edana Maher; Caroline Finn; Nuala Sammon; Sarah Fall; Noeleen Fallon; Evonne Hanrahan; Lisa King; Vincent Maher
Journal:  Ir J Med Sci       Date:  2018-06-01       Impact factor: 1.568

Review 3.  Genetic and environmental determinants of the susceptibility of Amerindian derived populations for having hypertriglyceridemia.

Authors:  Carlos A Aguilar-Salinas; Teresa Tusie-Luna; Päivi Pajukanta
Journal:  Metabolism       Date:  2014-03-30       Impact factor: 8.694

4.  Postprandial remodeling of high-density lipoprotein following high saturated fat and high carbohydrate meals.

Authors:  Michelle Averill; Katya B Rubinow; Kevin Cain; Jake Wimberger; Ilona Babenko; Jessica O Becker; Karen E Foster-Schubert; David E Cummings; Andrew N Hoofnagle; Tomas Vaisar
Journal:  J Clin Lipidol       Date:  2019-11-22       Impact factor: 4.766

5.  Remnant-Like Particle Cholesterol, Low-Density Lipoprotein Triglycerides, and Incident Cardiovascular Disease.

Authors:  Anum Saeed; Elena V Feofanova; Bing Yu; Wensheng Sun; Salim S Virani; Vijay Nambi; Josef Coresh; Cameron S Guild; Eric Boerwinkle; Christie M Ballantyne; Ron C Hoogeveen
Journal:  J Am Coll Cardiol       Date:  2018-07-10       Impact factor: 24.094

6.  A lifestyle intervention program for successfully addressing major cardiometabolic risks in persons with SCI: a three-subject case series.

Authors:  Gregory E Bigford; Armando J Mendez; Luisa Betancourt; Patricia Burns-Drecq; Deborah Backus; Mark S Nash
Journal:  Spinal Cord Ser Cases       Date:  2017-03-16

7.  Life-style-induced metabolic derangement and epigenetic changes promote diabetes and oxidative stress leading to NASH and atherosclerosis severity.

Authors:  Rai Ajit K Srivastava
Journal:  J Diabetes Metab Disord       Date:  2018-11-29

8.  Creation of Apolipoprotein C-II (ApoC-II) Mutant Mice and Correction of Their Hypertriglyceridemia with an ApoC-II Mimetic Peptide.

Authors:  Toshihiro Sakurai; Akiko Sakurai; Boris L Vaisman; Marcelo J Amar; Chengyu Liu; Scott M Gordon; Steven K Drake; Milton Pryor; Maureen L Sampson; Ling Yang; Lita A Freeman; Alan T Remaley
Journal:  J Pharmacol Exp Ther       Date:  2015-11-16       Impact factor: 4.030

9.  Differential Regulation of Gene Expression by Cholesterol Biosynthesis Inhibitors That Reduce (Pravastatin) or Enhance (Squalestatin 1) Nonsterol Isoprenoid Levels in Primary Cultured Mouse and Rat Hepatocytes.

Authors:  Elizabeth A Rondini; Zofia Duniec-Dmuchowski; Daniela Cukovic; Alan A Dombkowski; Thomas A Kocarek
Journal:  J Pharmacol Exp Ther       Date:  2016-05-25       Impact factor: 4.030

Review 10.  The polygenic nature of hypertriglyceridaemia: implications for definition, diagnosis, and management.

Authors:  Robert A Hegele; Henry N Ginsberg; M John Chapman; Børge G Nordestgaard; Jan Albert Kuivenhoven; Maurizio Averna; Jan Borén; Eric Bruckert; Alberico L Catapano; Olivier S Descamps; G Kees Hovingh; Steve E Humphries; Petri T Kovanen; Luis Masana; Päivi Pajukanta; Klaus G Parhofer; Frederick J Raal; Kausik K Ray; Raul D Santos; Anton F H Stalenhoef; Erik Stroes; Marja-Riitta Taskinen; Anne Tybjærg-Hansen; Gerald F Watts; Olov Wiklund
Journal:  Lancet Diabetes Endocrinol       Date:  2013-12-23       Impact factor: 32.069

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.